A Study to Evaluate the Efficacy and Safety of Zenapax in Combination With CellCept, Cyclosporine, and Corticosteroids in Patients Undergoing Cardiac Transplantation

Clinical trial NCT00048165 · COMPLETED

Trial details

NCT number: NCT00048165
Sponsor: Hoffmann-La Roche
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Heart Transplantation

Start date: 1999-08-01
Primary completion: 2002-08-01
Enrollment: 434

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.